SJM vs URGN · rev $9.05B vs rev $109.8M
JM Smucker Company (SJM) versus UroGen Pharma Ltd (URGN) — a side-by-side from cached financials, not a winner call.
JM Smucker Company (SJM) is a packaged foods company listed on US.
UroGen Pharma Ltd (URGN) is a biotechnology company listed on NASDAQ.
Latest reported SJM revenue for 2026-04-30 was $9.05B. Net income was -$138.7M. Revenue was up 3.7% from 2025-04-30 to 2026-04-30. SJM currently screens at market cap $11.10B.
Latest reported URGN revenue for 2025-12-31 was $109.8M. Net income was -$153.5M. URGN currently screens at market cap $1.61B.
SJM currently screens at market cap $11.10B. URGN currently screens at market cap $1.61B.
Not investment advice. Open the SJM and URGN stock pages for the full models.
Not investment advice.